Sudeep Pharma

58
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0QPI01025
  • NSEID: SUDEEPPHRM
  • BSEID: 544619
INR
1,192.30
-20.55 (-1.69%)
BSENSE

Nov 20

BSE+NSE Vol: 1.27 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
No of Months
12
12
12
12
Operating Income
642.00
501.00
459.00
428.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
Net Sales
642.00
501.00
459.00
428.00
Expenditure (Ex Depriciation)
Stock Adjustments
-42.00
-43.00
11.00
-17.00
Raw Materials Consumed
269.00
208.00
153.00
200.00
Power & Fuel Cost
12.00
10.00
9.00
10.00
Employee Cost
51.00
38.00
29.00
66.00
Operating Expenses
22.00
17.00
17.00
17.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
41.00
32.00
23.00
34.00
Cost of Software developments
0.00
0.00
0.00
0.00
Miscellaneous Expenses
11.00
5.00
4.00
8.00
Expenses Capitalised
0.00
0.00
0.00
0.00
Total Expenditure
419.00
310.00
276.00
338.00
Operating Profit (PBDIT) excl Other Income
222.00
191.00
182.00
90.00
Other Income
28.00
9.00
6.00
9.00
Operating Profit (PBDIT)
251.00
200.00
188.00
99.00
Interest
8.00
6.00
4.00
5.00
Profit before Depriciation and Tax
242.00
193.00
183.00
93.00
Depreciation
14.00
10.00
9.00
7.00
Profit Before Taxation & Exceptional Items
228.00
182.00
174.00
85.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
Profit Before Tax
228.00
182.00
174.00
85.00
Provision for Tax
53.00
44.00
41.00
23.00
Profit After Tax
174.00
138.00
133.00
62.00
Extraordinary Items
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
Profit Balance B/F
483.00
345.00
212.00
150.00
Profit Available for appropriations
656.00
484.00
346.00
212.00
Appropriations
656.00
484.00
346.00
212.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
15.50
12.79
12.28
5.74
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 27.94% vs 9.30% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 16.64% vs 4.68% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 23.21% vs 45.77% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 25.63% vs 4.16% in Mar 2025

Compare Profit and Loss Results of Sudeep Pharma
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
642.00
1,196.00
-554.00
-46.32%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
642.00
1,196.00
-554.00
-46.32%
Expenditure (Ex Depriciation)
Stock Adjustments
-42.00
-23.00
-19.00
-82.61%
Raw Materials Consumed
269.00
260.00
9.00
3.46%
Power & Fuel Cost
12.00
6.00
6.00
100.00%
Employee Cost
51.00
346.00
-295.00
-85.26%
Operating Expenses
22.00
6.00
16.00
266.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
41.00
111.00
-70.00
-63.06%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
11.00
59.00
-48.00
-81.36%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
419.00
956.00
-537.00
-56.17%
Operating Profit (PBDIT) excl Other Income
222.00
239.00
-17.00
-7.11%
Other Income
28.00
5.00
23.00
460.00%
Operating Profit (PBDIT)
251.00
245.00
6.00
2.45%
Interest
8.00
10.00
-2.00
-20.00%
Profit before Depriciation and Tax
242.00
235.00
7.00
2.98%
Depreciation
14.00
37.00
-23.00
-62.16%
Profit Before Taxation & Exceptional Items
228.00
198.00
30.00
15.15%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
228.00
198.00
30.00
15.15%
Provision for Tax
53.00
49.00
4.00
8.16%
Profit After Tax
174.00
149.00
25.00
16.78%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
483.00
377.00
106.00
28.12%
Profit Available for appropriations
656.00
527.00
129.00
24.48%
Appropriations
656.00
527.00
129.00
24.48%
Equity Dividend (%)
0%
73.1%
-73.10
Earnings Per Share
15.5
24.43
-8.93
-36.55%
Profit And Loss - Net Sales
Net Sales 642.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 27.94% vs 9.30% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 222.80 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.64% vs 4.68% in Mar 2025

Profit And Loss - Interest
Interest 8.50 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 23.21% vs 45.77% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 174.28 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 25.63% vs 4.16% in Mar 2025